Olema Pharmaceuticals
OLMA
OLMA
73 hedge funds and large institutions have $101M invested in Olema Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less capital invested
Capital invested by funds: $139M → $101M (-$37.6M)
33% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 24
Holders
73
Holding in Top 10
–
Calls
$231K
Puts
$32K
Top Buyers
| 1 | +$9.58M | |
| 2 | +$3.18M | |
| 3 | +$2.44M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$358K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$295K |
Top Sellers
| 1 | -$3.97M | |
| 2 | -$1.44M | |
| 3 | -$1.12M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$952K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$630K |